Becton Dickinson Quick Ratio (BDX) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Becton Dickinson And Company  (NYSE: BDX)

Becton Dickinson's Quick Ratio

BDX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 0.09 below Becton Dickinson And Company average.

Within Medical Equipment & Supplies industry 185 other companies have achieved higher Quick Ratio than Becton Dickinson in third quarter 2026. While Quick Ratio total ranking has improved so far during the Q3 2026 to 3760, from total ranking in the second quarter 2026 at 4679.

Explain Quick Ratio?
How much Cash & cash equivalents BDX´s has?
What are BDX´s Current Liabilities?




BDX Quick Ratio (Jun 30 2026)
Q3
(Mar 31 2026)
Q2
(Dec 31 2025)
Q1
(Sep 30 2025)
Q4
(Jun 30 2025)
Q3
Y / Y Current Liabilities Change 15.25 % 10.61 % -7.18 % 38.96 % 23.54 %
Y / Y Cash & cash equivalent Change 5.49 % 33.42 % -62.67 % -65.88 % -84.66 %
Quick Ratio MRQ 0.09 0.12 0.1 0.06 0.1
BDX's Total Ranking # 3760 # 4679 # 4766 # 4573 # 4605
Seq. Current Liabilities Change 10.54 % 2.33 % -33.2 % 52.51 % 6.1 %
Seq. Cash & cash equivalent Change -15.13 % 18.51 % 9.43 % -4.15 % 7.34 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 186
Healthcare Sector # 857
Overall Market # 3825


Quick Ratio Statistics
High Average Low
4.25 0.78 0.06
(Dec 31 2017)   (Sep 30 2025)




Financial Statements
Becton Dickinson's Current Liabilities $ 9,404 Millions Visit BDX's Balance sheet
Becton Dickinson's Cash & cash equivalent $ 864 Millions Visit BDX's Balance sheet
Source of BDX's Sales Visit BDX's Sales by Geography


Cumulative Becton Dickinson's Quick Ratio

BDX's Quick Ratio for the trailling 12 Months

BDX Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 14.53 % 16.2 % 14.96 % 26.15 % 23.47 %
Y / Y Cash & cash equivalent TTM Growth -42.98 % -67.48 % -75.49 % -62.2 % -46.4 %
Quick Ratio TTM 0.09 0.09 0.09 0.13 0.18
Total Ranking TTM # 3263 # 3846 # 2805 # 2745 # 2320
Seq. Current Liabilities TTM Growth 3.32 % 2.23 % -1.73 % 10.33 % 4.83 %
Seq. Cash & cash equivalent TTM Growth 1.29 % 7.9 % -30.89 % -24.51 % -42.22 %


On the trailing twelve months basis In Spite of the increase in Current Liabilities in the Q3 2026 to $9,404.00 millions, cumulative Quick Ratio remained unchanged at 0.09 below the Becton Dickinson And Company average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 206 other companies have achieved higher Quick Ratio than Becton Dickinson. While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending second quarter 2026 at 3226.

Explain Quick Ratio?
How much Cash & cash equivalents BDX´s has?
What are BDX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 207
Healthcare Sector # 911
Within the Market # 3760


trailing twelve months Quick Ratio Statistics
High Average Low
3.06 0.64 0.1
(Dec 31 2017)   (Dec 31 2025)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Cytosorbents Corporation  0.24 $ 4.413  Millions$ 18.320  Millions
U S Physical Therapy Inc  0.23 $ 24.887  Millions$ 109.909  Millions
Accuray Incorporated  0.21 $ 40.623  Millions$ 191.405  Millions
Cerus Corporation  0.21 $ 17.980  Millions$ 85.790  Millions
Tenon Medical Inc   0.20 $ 1.677  Millions$ 8.305  Millions
Bioventus Inc   0.19 $ 29.457  Millions$ 154.471  Millions
Avita Medical Inc   0.19 $ 13.096  Millions$ 68.714  Millions
Bausch and Lomb Corp  0.19 $ 367.000  Millions$ 1,942.000  Millions
Dentsply Sirona Inc   0.18 $ 239.000  Millions$ 1,319.000  Millions
Adm Tronics Unlimited Inc   0.18 $ 0.223  Millions$ 1.235  Millions
Catheter Precision Inc   0.16 $ 1.839  Millions$ 11.166  Millions
Zimmer Biomet Holdings Inc   0.14 $ 410.000  Millions$ 3,013.500  Millions
Nexgel Inc   0.12 $ 1.692  Millions$ 14.440  Millions
Ufp Technologies Inc   0.12 $ 9.045  Millions$ 78.304  Millions
Solventum Corporation  0.11 $ 403.000  Millions$ 3,663.000  Millions
Nakamoto Inc   0.11 $ 19.072  Millions$ 179.474  Millions
Petvivo Holdings Inc   0.10 $ 0.135  Millions$ 1.313  Millions
The Pennant Group Inc   0.10 $ 15.273  Millions$ 152.406  Millions
Non Invasive Monitoring Systems Inc  0.10 $ 0.160  Millions$ 1.607  Millions
Boston Scientific Corporation  0.10 $ 749.000  Millions$ 7,530.000  Millions
Integer Holdings Corporation  0.10 $ 21.375  Millions$ 217.141  Millions
Bellevue Life Sciences Acquisition Corp  0.10 $ 1.500  Millions$ 15.734  Millions
National Vision Holdings Inc   0.09 $ 35.998  Millions$ 383.026  Millions
Becton Dickinson And Company  0.09 $ 864.000  Millions$ 9,404.000  Millions
Vivos Therapeutics Inc   0.09 $ 1.774  Millions$ 20.389  Millions
The Cooper Companies Inc   0.08 $ 154.900  Millions$ 1,866.600  Millions
Infusystem Holdings Inc  0.06 $ 0.964  Millions$ 15.300  Millions
Vsee Health Inc   0.06 $ 0.454  Millions$ 8.139  Millions
P3 Health Partners Inc   0.05 $ 21.272  Millions$ 388.581  Millions
Henry Schein Inc   0.05 $ 157.000  Millions$ 3,488.000  Millions

Date modified: 2026-09-08T15:11:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.